Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19843481 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Interventions: Drug: Bepreve;   Drug: Placebo;   Drug: Bepotastine Besilate

Indicates status has not been verified in more than two years